May 22, 2023 / 04:00PM GMT
Felix Lauscher - Sanofi - Head of IR North America & Asia
Hello, everyone. I'm Felix Lauscher with Sanofi Investor Relations. Welcome to today's Sanofi investor call on respiratory, which coincides with the American Psoriatic Society Conference 2023 in Washington DC. We are looking forward to spending the next hour or so with you to review and discuss recent developments from Sanofi's respiratory portfolio. As usual, you can find the slides to this call on the Investor page of our website at sanofi.com.
Moving to Slide 3. I would like to remind you that information presented on this call contain forward-looking statements that involve known and unknown risks uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our (foreign language) for the description of these risk factors.
Advancing to Slide 4, you can see the agenda of today's call. We are particularly grateful for the participation of our 2 guest speakers: Surya Bhatt and Klaus Rabe, the 2 lead investigators of the BOREAS trial, who
Sanofi SA ATS Investor Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers